Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study

PURPOSE: Dydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and pregnancy outcomes. However, its safety regarding neonatal outcomes and congenital malformations is still unclear. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jialyu, Xie, Qin, Lin, Jiaying, Lu, Xuefeng, Wang, Ningling, Gao, Hongyuan, Cai, Renfei, Kuang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667350/
https://www.ncbi.nlm.nih.gov/pubmed/31440037
http://dx.doi.org/10.2147/DDDT.S210228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667350/
https://www.ncbi.nlm.nih.gov/pubmed/31440037
http://dx.doi.org/10.2147/DDDT.S210228

Ejemplares similares